{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:46:45Z","timestamp":1777394805107,"version":"3.51.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,8,14]]},"DOI":"10.3233\/jad-161224","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T11:10:28Z","timestamp":1500635428000},"page":"1307-1315","source":"Crossref","is-referenced-by-count":9,"title":["Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study"],"prefix":"10.1177","volume":"59","author":[{"given":"Brianne M.","family":"Bettcher","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery and Neurology, Rocky Mountain Alzheimer\u2019s Disease Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Colin","family":"Ard","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce R.","family":"Reed","sequence":"additional","affiliation":[{"name":"Center for Scientific Review, National Institute of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreana","family":"Benitez","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of South Carolina, Charleston, SC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Simmons","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Davis, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric B.","family":"Larson","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josh A.","family":"Sonnen","sequence":"additional","affiliation":[{"name":"Departmentof Pathology, University of Utah, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Montine","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University, Stanford, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine, Geriatric Research, Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Dirk","family":"Keene","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul K.","family":"Crane","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Mungas","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Davis, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-161224_ref1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1242\/dmm.010124","article-title":"Dysregulation of cholesterol balance in the brain: Contribution to neurodegenerative diseases","volume":"5","author":"Vance","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.3233\/JAD-161224_ref2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1749-6632.2000.tb06384.x","article-title":"Alterations of Alzheimer\u2019s disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations","volume":"903","author":"Sparks","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-161224_ref3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-161224_ref4","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","article-title":"Apolipoprotein E promotes beta-amyloid trafficking and degradation by modulating microglial cholesterol levels","volume":"287","author":"Lee","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-161224_ref5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease","volume":"137","author":"Kivipelto","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.3233\/JAD-161224_ref6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.JGP.0000310778.20870.ae","article-title":"Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis","volume":"16","author":"Anstey","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-161224_ref7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000231980","article-title":"Midlife serum cholesterol and increased risk of Alzheimer\u2019s and vascular dementia three decades later","volume":"28","author":"Solomon","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-161224_ref8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer\u2019s disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JAD-161224_ref9","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer\u2019s disease in later life: Longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.3233\/JAD-161224_ref10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-161224_ref11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/01.wnl.0000178989.87072.11","article-title":"Serum cholesterol and risk of Alzheimer disease: A community-based cohort study","volume":"65","author":"Li","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-161224_ref12","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","article-title":"High total cholesterol levels in late life associated with a reduced risk of dementia","volume":"64","author":"Mielke","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-161224_ref13","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archneurol.2010.297","article-title":"Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease","volume":"67","author":"Reitz","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-161224_ref14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000070182.02537.84","article-title":"Mild hypercholesterolemia is an early risk factor for thedevelopment of Alzheimer amyloid pathology","volume":"61","author":"Pappolla","year":"2003","journal-title":"Neurology"},{"key":"10.3233\/JAD-161224_ref15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/156720511795563755","article-title":"Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles","volume":"8","author":"Lesser","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-161224_ref16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000189268","article-title":"Serum lipids are related to Alzheimer\u2019s pathology in nursing home residents","volume":"27","author":"Lesser","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-161224_ref17","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1212\/WNL.0b013e31822e145d","article-title":"Association of Alzheimer disease pathology with abnormal lipid metabolism: The Hisayama Study","volume":"77","author":"Matsuzaki","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-161224_ref18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/WNL.57.8.1447","article-title":"Cholesterol and neuropathologic markers of AD: A population-based autopsy study","volume":"57","author":"Launer","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JAD-161224_ref19","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archneur.59.11.1737","article-title":"Dementia and Alzheimer disease incidence: A prospective cohort study","volume":"59","author":"Kukull","year":"2002","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-161224_ref20","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1161\/CIRCULATIONAHA.107.713438","article-title":"Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment","volume":"117","author":"Kastelein","year":"2008","journal-title":"Circulation"},{"issue":"Suppl 3","key":"10.3233\/JAD-161224_ref21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00014168","article-title":"Neuropathology of Alzheimer\u2019s disease: What is new since A. Alzheimer?","volume":"249","author":"Braak","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-161224_ref22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-161224_ref23","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0197-4580(97)00058-4","article-title":"The CERAD neuropathology protocol and consensusrecommendations for the postmortem diagnosis of Alzheimer\u2019sdisease: A commentary","volume":"18","author":"Mirra","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-161224_ref24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.3233\/JAD-161224_ref25","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/01.STR.28.7.1418","article-title":"Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy","volume":"28","author":"Greenberg","year":"1997","journal-title":"Stroke"},{"key":"10.3233\/JAD-161224_ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-161224_ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-161224_ref28","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson\u2019s disease: Refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-161224_ref29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ana.21208","article-title":"Pathological correlates of dementia in a longitudinal, population-based sample of aging","volume":"62","author":"Sonnen","year":"2007","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-161224_ref30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","article-title":"The evolution of preclinical Alzheimer\u2019s disease: Implications for prevention trials","volume":"84","author":"Sperling","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-161224_ref31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"J Cell Biol"},{"issue":"Suppl 2","key":"10.3233\/JAD-161224_ref32","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.neurobiolaging.2014.03.037","article-title":"Apolipoprotein E and lipid homeostasis in theetiology and treatment of sporadic Alzheimer\u2019s disease","volume":"35","author":"Poirier","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-161224_ref33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0404.2006.00685.x","article-title":"Cholesterol as a risk factor for Alzheimer\u2019s disease - epidemiological evidence","volume":"185","author":"Kivipelto","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.3233\/JAD-161224_ref34","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.2017.3090","article-title":"Association between midlife vascular risk factors and estimated brain amyloid deposition","volume":"317","author":"Gottesman","year":"2017","journal-title":"JAMA"},{"key":"10.3233\/JAD-161224_ref35","first-page":"836962","article-title":"Total cholesterol and the risk of Parkinson\u2019s disease: A review for some new findings","volume":"2010","author":"Hu","year":"2010","journal-title":"Parkinsons Dis"},{"key":"10.3233\/JAD-161224_ref36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exger.2014.09.013","article-title":"Does the oxysterol 27-hydroxycholesterol underlie Alzheimer\u2019s disease-Parkinson\u2019s disease overlap?","volume":"68","author":"Marwarha","year":"2015","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-161224_ref37","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1471-4159.2008.05736.x","article-title":"Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells","volume":"107","author":"Rantham Prabhakara","year":"2008","journal-title":"J Neurochem"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-161224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:17Z","timestamp":1777370657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-161224"}},"subtitle":[],"editor":[{"given":"Kaarin","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,14]]},"references-count":37,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-161224","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,14]]}}}